comprehensive -WSS

comprehensive

author：Wikipedia 2025-10-01 14:15:53 - browse：81

Richard Neal(D-MA), Rep. Frank Pallone (D-NJ),Rep. John Yarmuth (D-KY), Rep. Bobby Scott (D-VA) and House Minority Leader Nancy Pelosi (D-CA) attend the weekly press conference in the Capitol building on July 20, 2017 in Washington, DC. They spoke to the media about the efforts to reform the health care bill. -- health policy coverage from STAT — Reps. Richard Neal (D-Mass.), Rep. Frank Pallone (D-N.J.), and Rep. John Yarmuth (D-Ky.) Joe Raedle/Getty Images

WASHINGTON — It’s drug pricing déjà vu: Just as they did in 2019, House Democrats are pushing a bill that would allow Medicare to negotiate dozens of drug prices a year, offer those prices to all insurers, and crack down on price hikes.

Unlike then, Democrats have a starting place: the new bill represents an expansion of the major drug pricing legislation the party passed last year. But the first round of drug price negotiations hasn’t even started yet, and the law is under attack from the pharmaceutical industry in court.

The Democratic leaders of three key House committees put forth the proposal Wednesday.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Indian pharmaceutical industry in denial over drug

hotspot

knowledge

WSS

MassMutual is introducing free genetic testing for members

Mass General totes up its waste in a move to tackle climate change

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Texas Department of Public Safety speaks out on migrant abuse allegations

Tesla recalling nearly 16,000 of its 2021

Cue Health's Covid

knowledge

comprehensive

focus

The high cost of giving birth even with insurance

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Medicare details structure of new drug price negotiation program

Tocagen's brain cancer gene therapy trial continues. Investors worry

Bright Health sells Medicare Advantage business to Molina

Melinda French Gates resigns from Gates Foundation

Walensky prepares to leave CDC — and Congress — behind

Wildfires rage amid heat wave in Greece, prompting evacuations and call for European support

Heart attack and stroke risk calculators need revising

Why rehabilitation engineers need to center patients in their research

explore

Cell therapy fails to slow type 1 diabetes, but safety is established

More tobacco lobbyists active in statehouses

Melinda French Gates resigns from Gates Foundation

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Exact Sciences stock tumbles despite strong cancer detection sales

Study identifies new proteins linked to dementia risk 25 years later

hotspot

leisure time

knowledge

hotspot